Join
Live feed
·
INSIDERFilingvia Quantisnow
Marinus Pharmaceuticals Inc. logo

Director Mayleben Timothy M was granted 2,300 shares, increasing direct ownership by 10% to 24,375 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MRNS· Marinus Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRNS (Marinus Pharmaceuticals Inc.) and more on Quantisnow.